Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Volaris Group has completed the acquisition of Interplayers, a healthcare IT business in São Paulo, Brazil, for $X. Interplayers is a digital solutions hub connecting pharmacies, clinics, and laboratories across Brazil, supporting access, operational efficiency, and value creation for the healthcare ecosystem. Volaris Group acquires Interplayers to expand its international healthcare IT footprint in Latin America and strengthen relationships with local healthcare stakeholders. The healthcare M&A is structured as an add-on acquisition within Volaris Group acquisitions, with Interplayers operating as an independent business unit and retaining its leadership under CEO Rodrigo Galesi. The strategic acquisition was announced on April 30, 2026, with founder Arnaldo Sá Filho continuing as an advisor.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Tenet Healthcare→United Surgical Partners International
Apr 30, 2026
Vitalist→Somatix
Apr 30, 2026